Product Information
CILOSTAZOL 50 MG TABLET is a generic product labeled by Slate Run Pharmaceuticals LLC, priced at $0.1304 per EA under NDC 70436015606. Its NADAC has been published 273 times since Jul 14, 2021.
FDA first approved this application on Mar 29, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Slate Run Pharmaceuticals LLCNDC
70436015606
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CILOSTAZOLApproval Type
Generic (ANDA)
FDA Application
ANDA077208FDA Approved
3/29/2006
TE Code
AB
On Market Since
1/1/2018
Pharmacological Classes
Price Statistics
The NADAC for CILOSTAZOL 50 MG TABLET has been published 273 times since Jul 14, 2021, and over the history we have for it it has risen 9.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1304 per EA |
|---|---|
| All-time high | $0.1435 (Mar 13, 2024) |
| All-time low | $0.1008 (May 22, 2024) |
| 52-week high | $0.1304 |
| 52-week low | $0.1077 |
| Median price | $0.1159 |
| Average price | $0.1174 |
| Largest weekly change | +25.1% (Feb 21, 2024) |
| Weeks tracked | 273 |
| Tracking since | Jul 14, 2021 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Slate Run Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
cilostazol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phosphodiesterase 3 Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CILOSTAZOL 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CILOSTAZOL 50 MG TABLET, manufactured by Slate Run Pharmaceuticals LLC, is $0.1304 per EA (NDC 70436015606), effective Sep 30, 2026.
How has the price of CILOSTAZOL 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for CILOSTAZOL 50 MG TABLET has risen 9.0%. It has been tracked across 273 weekly CMS publications since Jul 14, 2021.
What are the highest and lowest recorded NADAC prices for CILOSTAZOL 50 MG TABLET?
Since Jul 14, 2021, the NADAC for CILOSTAZOL 50 MG TABLET has ranged from a low of $0.1008 (May 22, 2024) to a high of $0.1435 (Mar 13, 2024), with a median of $0.1159 per EA.
Are there cheaper alternatives to CILOSTAZOL 50 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CILOSTAZOL 50 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CILOSTAZOL 50 MG TABLET?
CILOSTAZOL 50 MG TABLET (NDC 70436015606) is labeled by Slate Run Pharmaceuticals LLC, and CMS classifies it as a generic product.